Ocular toxicity of anandron.-Reference-Cited by-同舟云学术

Ocular toxicity of anandron.

Published:1987-08-01 Issue:8 Volume:71 Page:639-640
ISSN:0007-1161
Container-title:British Journal of Ophthalmology
language:en
Short-container-title:British Journal of Ophthalmology

Author:

Brisset J M,Bertagna C,Proulx L

Publisher

BMJ

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference10 articles.

1. New approach in the treatment of prostate cancer: complete instead of only partial withdrawal of androgens;A, I.Labrie F.Dupont; A, Belanger;Prostate,1983

2. Combined antihormonal treatment in prostate cancer, a new approach using an LHRH agonist or castration and an antiandrogen;Labric, F.; Dupont, A.; Belanger, A.,1984

3. Ocular toxicity of Anandron in patients treated for prostatic cancer;Harnois, C.; Dupont, Malenfant M.; A, Labrie; F.;BrJ Ophthalmol,1986

4. Anandron (RU 23908) associated to surgical castration in previously untreated stage D prostate cancer: multiccnter comparative study of two doses of the drug and of a placebo;Brisset, J.M.; Boccon-Gibod, L.; Botto, H.,1986

5. Double-blind study of Anandron versus placebo in stage D2 prostate cancer patients receiving buserelin. Results of 49 cases from a multicenter study;Navratil, H.,1986

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic Drugs;Drug-Induced Ocular Side Effects;2021

2. Drug-induced ocular side effects;Drug-Induced Ocular Side Effects;2015

3. Drug-induced ocular side effects;Clinical Ocular Toxicology;2008

4. Non-steroidal anti-androgens in prostate cancer - current treatment practice;Expert Opinion on Pharmacotherapy;2000-03

5. Tolerability of Nonsteroidal Antiandrogens in the Treatment of Advanced Prostate Cancer;The Oncologist;1997-02-01